684 related articles for article (PubMed ID: 9299855)
1. The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients.
Prandoni P; Villalta S; Bagatella P; Rossi L; Marchiori A; Piccioli A; Bernardi E; Girolami B; Simioni P; Girolami A
Haematologica; 1997; 82(4):423-8. PubMed ID: 9299855
[TBL] [Abstract][Full Text] [Related]
2. Long-term clinical follow-up in 265 patients with deep venous thrombosis initially treated with either unfractionated heparin or dalteparin: a retrospective analysis.
Holmström M; Aberg W; Lockner D; Paul C
Thromb Haemost; 1999 Oct; 82(4):1222-6. PubMed ID: 10544902
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of mesoglycan in patients with previous deep venous thrombosis and chronic venous insufficiency.
Andreozzi GM
Minerva Cardioangiol; 2007 Dec; 55(6):741-53. PubMed ID: 18091643
[TBL] [Abstract][Full Text] [Related]
4. The long-term clinical course of acute deep venous thrombosis.
Prandoni P; Lensing AW; Cogo A; Cuppini S; Villalta S; Carta M; Cattelan AM; Polistena P; Bernardi E; Prins MH
Ann Intern Med; 1996 Jul; 125(1):1-7. PubMed ID: 8644983
[TBL] [Abstract][Full Text] [Related]
5. Incidence, natural history and risk factors of deep vein thrombosis in elective knee arthroscopy.
Delis KT; Hunt N; Strachan RK; Nicolaides AN
Thromb Haemost; 2001 Sep; 86(3):817-21. PubMed ID: 11583313
[TBL] [Abstract][Full Text] [Related]
6. The natural history of deep-vein thrombosis.
Prandoni P; Lensing AW; Prins MR
Semin Thromb Hemost; 1997; 23(2):185-8. PubMed ID: 9200345
[TBL] [Abstract][Full Text] [Related]
7. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
8. Blood coagulation and thrombosis in patients with ovarian malignancy.
von Tempelhoff GF; Dietrich M; Niemann F; Schneider D; Hommel G; Heilmann L
Thromb Haemost; 1997 Mar; 77(3):456-61. PubMed ID: 9065993
[TBL] [Abstract][Full Text] [Related]
9. Oral anticoagulant therapy in venous thromboembolism.
Cosmi B; Palareti G
Semin Vasc Med; 2003 Aug; 3(3):303-14. PubMed ID: 15199464
[TBL] [Abstract][Full Text] [Related]
10. Home treatment of deep venous thrombosis with low molecular weight heparin: Long-term incidence of recurrent venous thromboembolism.
Grau E; Tenias JM; Real E; Medrano J; Ferrer R; Pastor E; Selfa S
Am J Hematol; 2001 May; 67(1):10-4. PubMed ID: 11279651
[TBL] [Abstract][Full Text] [Related]
11. The occurrence of subsequent malignancy in patients presenting with deep vein thrombosis: results from a historical cohort study.
Rajan R; Levine M; Gent M; Hirsh J; Geerts W; Skingley P; Julian J
Thromb Haemost; 1998 Jan; 79(1):19-22. PubMed ID: 9459315
[TBL] [Abstract][Full Text] [Related]
12. Effect of the anticoagulant therapy in the incidence of post-thrombotic syndrome and recurrent thromboembolism: Comparative study of enoxaparin versus coumarin.
González-Fajardo JA; Martin-Pedrosa M; Castrodeza J; Tamames S; Vaquero-Puerta C
J Vasc Surg; 2008 Oct; 48(4):953-9. PubMed ID: 18639417
[TBL] [Abstract][Full Text] [Related]
13. Home treatment of deep vein thrombosis: a two-years experience of a single institution.
Grau E; Real E; Pastor E; Viciano V; Aguiló J
Haematologica; 1998 May; 83(5):438-41. PubMed ID: 9658729
[TBL] [Abstract][Full Text] [Related]
14. Short-term clinical outcome after acute symptomatic pulmonary embolism.
Conget F; Otero R; Jiménez D; Martí D; Escobar C; Rodríguez C; Uresandi F; Cabezudo MA; Nauffal D; Oribe M; Yusen R
Thromb Haemost; 2008 Nov; 100(5):937-42. PubMed ID: 18989541
[TBL] [Abstract][Full Text] [Related]
15. Comparative study on risk factors and early outcome of symptomatic distal versus proximal deep vein thrombosis: results from the OPTIMEV study.
Galanaud JP; Sevestre-Pietri MA; Bosson JL; Laroche JP; Righini M; Brisot D; Boge G; van Kien AK; Gattolliat O; Bettarel-Binon C; Gris JC; Genty C; Quere I;
Thromb Haemost; 2009 Sep; 102(3):493-500. PubMed ID: 19718469
[TBL] [Abstract][Full Text] [Related]
16. Post-thrombotic syndrome: prevalence, prognostication and need for progress.
Prandoni P; Kahn SR
Br J Haematol; 2009 May; 145(3):286-95. PubMed ID: 19222476
[TBL] [Abstract][Full Text] [Related]
17. [Prospective 12-year follow-up study of clinical and hemodynamic sequelae of deep venous thromboses in patients with low risk (Zurich Study)].
Franzeck UK; Schalch I; Jäger KA; Grimm ES; Bollinger A
Wien Med Wochenschr; 1999; 149(2-4):78-84. PubMed ID: 10378331
[TBL] [Abstract][Full Text] [Related]
18. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped.
Palareti G; Legnani C; Cosmi B; Guazzaloca G; Pancani C; Coccheri S
Thromb Haemost; 2002 Jan; 87(1):7-12. PubMed ID: 11848459
[TBL] [Abstract][Full Text] [Related]
19. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group.
Schulman S; Granqvist S; Holmström M; Carlsson A; Lindmarker P; Nicol P; Eklund SG; Nordlander S; Lärfars G; Leijd B; Linder O; Loogna E
N Engl J Med; 1997 Feb; 336(6):393-8. PubMed ID: 9010144
[TBL] [Abstract][Full Text] [Related]
20. [Long-term sequelae of deep venous thrombosis of the legs. Experience with mesoglycan].
Prandoni P; Cattelan AM; Carta M
Ann Ital Med Int; 1989; 4(4):378-85. PubMed ID: 2535067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
